Cayman Chemical TaccalonlIde B 10mg
An SGLT1 and SGLT2 inhibitor (IC50s 22.8 and 2.3 UM respectively) dietary administration reduces blood glucose and HbA1c levels in a rat model of streptozotocin-induced diabetes at 0.01 w/w suppresses the development of hyperglycemia and hypertriglyceridemia and reduces HbA1c levels in the KKAY mouse model of type 2 diabetes exacerbates post-infarction cardiac dysfunction in a rat model of left anterior descending coronary artery ligation-induced myocardial infarction